Showing results (21-30 of 192) with videos related to
Sort By:
Pageof 20
Mayo Clinic Proceedings|May 13, 2005
Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversityDavid P Steensma, Alan F ListJournal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Developmental therapeutics for myelodysplastic syndromesAung Naing, Lubomir Sokol, Alan F ListClinical Advances in Hematology & Oncology : H&O|June 14, 2014
The clinical management of chronic myelomonocytic leukemiaEric Padron, Rami Komrokji, Alan F ListExpert Review of Hematology|February 17, 2011
Biology and treatment of the 5q- syndromeEric Padron, Rami Komrokji, Alan F ListClinical Lymphoma, Myeloma & Leukemia|August 12, 2018
SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5qChetasi Talati, David Sallman, Alan F ListCurrent Opinion in Hematology|May 27, 2009
Advancements in the molecular pathogenesis of myelodysplastic syndromePearlie K Epling-Burnette, Alan F ListCurrent Treatment Options in Oncology|October 4, 2011
The 5q- syndrome: biology and treatmentEric Padron, Rami Komrokji, Alan F ListBlood|October 7, 2016
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemiaMarkus Ball, Alan F List, Eric PadronCurrent Hematologic Malignancy Reports|April 29, 2010
Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more?Rami S Komrokji, Jeffrey E Lancet, Alan F ListHematology Reports|December 21, 2011
Immune dysregulation in myelodysplastic syndromeChiharu Sugimori, Alan F List, Pearlie K Epling-BurnettePageof 20